The document discusses administering medications intravenously through bolus injection or infusion. It describes the terms intravenous and bolus injection, and outlines principles for verifying qualifications, reviewing preparation and administration, identifying effects, and documenting procedures. Potential complications of peripheral intravenous therapy include phlebitis, infiltration, extravasation, hemorrhage, local infection, pulmonary edema, air embolism, catheter embolism, and catheter-related bloodstream infection. Equipment used includes gloves, tourniquet, antiseptic wipes, syringe, cannula, saline, drip set, IV fluid, adhesive plaster, tray, and towel.
Central Venous Catheter Care- A Nursing skill Tse Sona
- Shared on the request of al the delegates who attended and those who couldn't attend the webinar on "CVC care- A Nursing Skill'' due to limited seats. I hope it will be helpful to all
Central Venous Catheter Care- A Nursing skill Tse Sona
- Shared on the request of al the delegates who attended and those who couldn't attend the webinar on "CVC care- A Nursing Skill'' due to limited seats. I hope it will be helpful to all
This presentation is about Iv injection which is used by all health professionals to the patients. This presentation includes definition, purpose, types, equipment with procedure and role of nurse all are included.. this is very helpful demonstration for health care settings.
Parenteral route of Medication Administration. In this Intramuscular & Intravenous Injection is a part, here Explained about the sites, needed articles, Indication, Contra Indication, Complications & step wise Procedure was explained.
Safe iv cannulation (prevention of iv thrombophlebitis)Chaithanya Malalur
A basic introduction to applying an intravenous canula. A note on commonly accessible veins, purpose of IV cannulation, materials & procedure, after care, complications & management
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. Some medications must be given by
an intravenous (IV) injection or
infusion.
This means they’re sent directly into
your vein using a needle or tube.
4. × This involves a single injection of a concentrated
solution directly into an IV line.
× Drugs given by IV push are used for intermittent
dosing or to treat emergencies.
× The drug is administered very slowly over at least 1
minute.
5. × This can be done manually or a syringe pump may
be used.
6. Principles:
1: Verify qualifications
for administration
× Are you qualified to
give this medication?
What supervision is
required? What
resources must you
consult?
7. × Review route of
administration and
IV site.
× Can this medication be
given by the IV route?
× Is the route of
administration (needle
insertion site) free from
redness, swelling, and
discomfort?
8. × Review
preparatio
n and how
to
administer
the
medicatio
n.
× Preparation and supplies: is a pre-flush
required?
× Patient identification: any allergies?
× Administration rate: what is the correct rate
of administration (over 1 minute, 5
minutes)?
10. × Assess dose and
range (e.g., 5 to 10
mg).
× Is the ordered dose
safe?
× When did the patient
last receive this
medication?
× What was the effect of
the medication on the
patient?
11. × Understand the
therapeutic effect.
× What is the expected
therapeutic effect of
the medication?
× What pre-assessment
determines if the
medication is correct
for the patient?
12. × Know adverse
effects.
× What are the potential
adverse effects of the
medications?
× How would you
manage these
adverse effects?
× Is there an antidote?
30. Which principle we are following if; Can this
medication be given by the IV route? Is the
route of administration (needle insertion
site) free from redness, swelling, and
discomfort?
1. Identify when medication starts to work
2. Review preparation and how to administer the
medication.
3. Verify qualifications for administration
4. Review route of administration and IV site.
31. What measures keep in mind, if a
medication is added into the IV fluid?
1. Apply label of medication
2. Instill it with NS
3. The fluid should be half empty
4. The fluid should be full filled
32. Which principle we are following if;
is a pre-flush required?
Patient identification: any allergies?
Administration rate: what is the correct rate of
administration (over 1 minute, 5 minutes)?
1. Identify when medication starts to work
2. Review preparation and how to administer the
medication.
3. Verify qualifications for administration
4. Review route of administration and IV site.
33. Which principle we are following if;
What is the onset, peak, and duration of the
medication?
1. Identify when medication starts to work
2. Review preparation and how to administer the
medication.
3. Verify qualifications for administration
4. Review route of administration and IV site
41. Phlebitis
× Phlebitis is the
inflammation of the vein’s
inner lining, the tunica
intima.
× Clinical indications are
localized redness, pain,
heat, and swelling, which
can track up the vein
leading to a palpable
42. Infiltration
× Infiltration occurs when a non-vesicant
solution (IV solution) is inadvertently
administered into surrounding tissue.
× Signs and symptoms include pain, swelling,
redness, skin surrounding insertion site is
cool to touch, change in quality or flow of IV,
tight skin around IV site, IV fluid leaking from
IV site, and frequent alarms on the IV pump.
43.
44. × Extravasation occurs when vesicant solution
(medication) is administered and inadvertently leaks
into surrounding tissue, causing damage to
surrounding tissue.
× Characterized by the same signs and symptoms as
infiltration but also includes burning, stinging,
redness, blistering, or necrosis of the tissue.
49. × Pulmonary edema, also known as fluid
overload or circulatory overload, is a condition
caused by excess fluid accumulation in the
lungs, due to excessive fluid in the circulatory
system.
50.
51. × Air embolism refers to the presence of air
in the vascular system and occurs when
air is introduced into the venous system
and travels to the right ventricle and/or
pulmonary circulation.
52.
53. × A catheter embolism occurs when a small
part of the cannula breaks off and flows into
the vascular system.
54. Catheter-related bloodstream infection
× Catheter-related bloodstream infection (CR-
BSI) is caused by microorganisms that are
introduced into the blood through the puncture
site, the hub, or contaminated IV tubing or IV
solution, leading to bacteremia or sepsis.
55. × when a small part of the cannula breaks off and
flows into the vascular system. IT IS TERMED
AS??
1. Air embolism
2. Catheter embolism
3. Thrombus
4. Embolie
56. × presence of air in the vascular system and
occurs when air is introduced into the venous
system IT IS TERMED AS??
1. Air embolism
2. Catheter embolism
3. Thrombus
4. Embolie
57. × condition caused by excess fluid accumulation
in the lungs, due to excessive fluid in the
circulatory system. Termed as? Air embolism
1. Haemorrhage
2. Thrombus
3. Phlebitis
4. Pulmonary oedema
58. × inflammation of the vein’s inner lining, the tunica
intima is known as???
1. Haemorrhage
2. Thrombus
3. Phlebitis
4. Pulmonary oedema
59. × Bleeding from the puncture site is known as?
1. Hemorrhage
2. Thrombus
3. Phlebitis
4. Pulmonary oedema